Abstract 4718: Potent preclinical antitumor effects induced by pan-histone deacetylase inhibitor panobinostat in combination with sorafenib in hepatocellular carcinoma
2011 ◽
Vol 2
(2)
◽
pp. 127-135
◽
2018 ◽
Vol 68
(3)
◽
pp. 379-393
◽
2006 ◽
Vol 12
(17)
◽
pp. 5199-5206
◽
2012 ◽
Vol 83
(2)
◽
pp. e181-e189
◽